AP Anacor Pharmaceuticals, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Anacor Pharmaceuticals, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 5 February 2016 (Attribution). Among the most active insiders: IPPOLITO VINCENT P. Every trade is openly available.
Analyst consensus: bullish or bearish? Analysts rate Anacor Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 February 2016
All Executives21 Thresholds0 Prospectus0 Other0
Declarations 21 total
◆ EVP and General Counsel · Executives · 3 Feb 2016
6,250 shares Common Stock SEC:0001209191-16-096107:0
◆ EVP & Chief Commercial Officer · Executives · 3 Feb 2016
5,000 shares Common Stock SEC:0001209191-16-096109:0
◆ SVP and Chief Medical Officer · Executives · 3 Feb 2016
4,375 shares Common Stock SEC:0001209191-16-096112:0
◆ Executive VP and CFO · Executives · 3 Feb 2016
5,000 shares Common Stock SEC:0001209191-16-096102:0
◆ President and CEO · Executives · 3 Feb 2016
14,584 shares Common Stock SEC:0001209191-16-096104:0
◇ SVP and Chief Medical Officer · Executives · 22 Jan 2016
11,800 shares Common Stock SEC:0001209191-16-093488:0
◇ EVP & Chief Commercial Officer · Executives · 19 Jan 2016
20,000 shares Common Stock SEC:0001209191-16-092996:0
▼ EVP & Chief Commercial Officer · Executives · 19 Jan 2016
1,200 shares Common Stock SEC:0001209191-16-092996:1
▼ EVP & Chief Commercial Officer · Executives · 19 Jan 2016
13,300 shares Common Stock SEC:0001209191-16-092996:2
▼ EVP & Chief Commercial Officer · Executives · 19 Jan 2016
5,300 shares Common Stock SEC:0001209191-16-092996:3
▼ EVP & Chief Commercial Officer · Executives · 19 Jan 2016
200 shares Common Stock SEC:0001209191-16-092996:4
▼ SVP and Chief Medical Officer · Executives · 15 Jan 2016
1,466 shares Common Stock SEC:0001209191-16-092267:0
▼ President and CEO · Executives · 4 Jan 2016
80 shares Common Stock SEC:0001209191-16-089483:0
▼ Sr. VP and General Counsel · Executives · 4 Jan 2016
333 shares Common Stock SEC:0001209191-16-089485:1
▼ Sr. VP and General Counsel · Executives · 4 Jan 2016
200 shares Common Stock SEC:0001209191-16-089485:2
▼ EVP & Chief Commercial Officer · Executives · 4 Jan 2016
100 shares Common Stock SEC:0001209191-16-089486:0
▼ EVP & Chief Commercial Officer · Executives · 4 Jan 2016
555 shares Common Stock SEC:0001209191-16-089486:1
▼ EVP & Chief Commercial Officer · Executives · 4 Jan 2016
200 shares Common Stock SEC:0001209191-16-089486:2
▼ President and CEO · Executives · 4 Jan 2016
233 shares Common Stock SEC:0001209191-16-089483:2
▼ Sr. VP and General Counsel · Executives · 4 Jan 2016
200 shares Common Stock SEC:0001209191-16-089485:0
▼ President and CEO · Executives · 4 Jan 2016
2,220 shares Common Stock SEC:0001209191-16-089483:1
关于 Anacor Pharmaceuticals, Inc. Anacor Pharmaceuticals, Inc. 是一家生物制药公司,专注于开发皮肤病治疗方法。该公司在纳斯达克上市,股票代码为 ANAC。